Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Helius Medical Technologies, Inc. Class A Common Stock (DE) (HSDT)

Electromedical & Electrotherapeutic Apparatus

https://www.heliusmedical.com

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

642 NEWTOWN YARDLEY ROAD
NEWTOWN, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/27/2014

Market Cap

2,593,818

Shares Outstanding

710,000

Weighted SO

708,247

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

NUWE --.--%

RSLS --.--%

BBLG --.--%

SINT --.--%

TIVC --.--%

TLIS --.--%

BJDX --.--%

HSCS --.--%

Beta

1.6090

Last Div

0.0000

Range

0.65-13.43

Chg

0.0252

Avg Vol

117632

Mkt Cap

2593818

Exch

NASDAQ

Country

US

Phone

215 944 6100

DCF Diff

-2.6351

DCF

5.0551

Div Yield

0.0000

P/S

4.3667

EV Multiple

0.3382

P/FV

0.2881

Div Yield %

0.0000

P/E

-0.2067

PEG

-0.0030

Payout

0.0000

Current Ratio

4.1974

Quick Ratio

3.7982

Cash Ratio

3.1050

DSO

404.9411

DIO

562.2233

Op Cycle

967.1643

DPO

881.3415

CCC

85.8229

Gross Margin

0.1027

Op Margin

-20.3451

Pretax Margin

-14.8754

Net Margin

-14.8754

Eff Tax Rate

-0.0716

ROA

-0.9989

ROE

-2.5806

ROCE

-1.7801

NI/EBT

1.0000

EBT/EBIT

0.7312

EBIT/Rev

-20.3451

Debt Ratio

0.0040

D/E

0.0055

LT Debt/Cap

0.0000

Total Debt/Cap

0.0055

Int Coverage

-219.7273

CF/Debt

-296.5143

Equity Multi

1.3955

Rec Turnover

0.9014

Pay Turnover

0.4141

Inv Turnover

0.6492

FA Turnover

3.0306

Asset Turnover

0.0671

OCF/Share

-4.1214

FCF/Share

-4.1270

Cash/Share

2.5365

OCF/Sales

-17.4714

FCF/OCF

1.0013

CF Coverage

-296.5143

ST Coverage

-296.5143

CapEx Coverage

-741.2856

Div&CapEx Cov

-741.2856

P/BV

0.2881

P/B

0.2881

P/S

4.3667

P/E

-0.2067

P/FCF

-0.2496

P/OCF

-0.1760

P/CF

-0.1760

PEG

-0.0030

P/S

4.3667

EV Multiple

0.3382

P/FV

0.2881

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jun 05, 01:12 Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering GlobeNewswire Inc. Nov 30, 07:47 Helius Medical Technologies to Present at NobleCon19 Annual Conference GlobeNewswire Inc. Nov 02, 17:05 Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024

Revenue Product Segmentation